P. Castellani

发表

Validation and comparison of indexes for fibrosis and cirrhosis prediction in chronic hepatitis C patients: proposal for a pragmatic approach classification without liver biopsies

D. Ouzan, C. Degott, A. Tran, 2006, Journal of viral hepatitis.

Hepatocellular carcinoma macroscopic gross appearance on imaging: predictor of outcome after transarterial chemoembolization in a real-life multicenter French cohort.

J. Raoul, M. Bourlière, G. Pénaranda, 2019, European journal of gastroenterology & hepatology.

Impact of direct-acting antiviral agents on the risk for hepatocellular carcinoma.

M. Bourlière, X. Adhoute, P. Castellani, 2017, Translational gastroenterology and hepatology.

Traitement de l’hépatite chronique B : nouvelles perspectives New perspective in chronic hepatitis B therapy

P. Castellani, M. Bourlière, 2008 .

Sorafenib: Experience and Better Management of Side Effects Improve Overall Survival in Hepatocellular Carcinoma Patients: A Real-Life Retrospective Analysis

J. Raoul, M. Bourlière, G. Pénaranda, 2019, Liver Cancer.

Absence of hepatitis C genome in semen of infected men by polymerase chain reaction, branched DNA and in situ hybridization.

P. Halfon, M. Bourlière, P. Cau, 2000, Liver.

Recommendations for the use of chemoembolization in patients with hepatocellular carcinoma: Usefulness of scoring system?

M. Bourlière, G. Pénaranda, X. Adhoute, 2015, World journal of hepatology.

Prognosis of advanced hepatocellular carcinoma: a new stratification of Barcelona Clinic Liver Cancer stage C results from a French multicenter study

J. Blanc, J. Raoul, M. Bourlière, 2015, European journal of gastroenterology & hepatology.

How to optimize current therapy of HCV genotype 1 infection with boceprevir

M. Bourlière, X. Adhoute, C. Ansaldi, 2014, Liver international : official journal of the International Association for the Study of the Liver.

Sofosbuvir, velpatasvir and voxilaprevir: a new triple combination for hepatitis C virus treatment. One pill fits all? Is it the end of the road?

M. Bourlière, X. Adhoute, P. Castellani, 2018, Therapeutic advances in gastroenterology.

Sofosbuvir plus ledipasvir in combination for the treatment of hepatitis C infection

P. Halfon, M. Bourlière, I. Portal, 2015, Expert review of gastroenterology & hepatology.

Sofosbuvir as backbone of interferon free treatments.

M. Bourlière, X. Adhoute, C. Ansaldi, 2014, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

ofosbuvir as backbone of interferon free treatments arc

X. Adhoute, C. Ansaldi, P. Castellani, 2014 .

Clinical relevance of the HCV protease inhibitor-resistant mutant viral load assessed by ultra-deep pyrosequencing in treatment failure.

D. Olive, L. Chiche, P. Halfon, 2016, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Chronic hepatitis C: future treatment

M. Bourlière, X. Adhoute, C. Ansaldi, 2014, Clinical pharmacology : advances and applications.

Detection of IL28B SNP DNA from Buccal Epithelial Cells, Small Amounts of Serum, and Dried Blood Spots

D. Ouzan, P. Halfon, M. Bourlière, 2012, PloS one.

A single IL28B genotype SNP rs12979860 determination predicts treatment response in patients with chronic hepatitis C Genotype 1 virus

D. Ouzan, A. Tran, C. Renou, 2011, European journal of gastroenterology & hepatology.

Second-line therapy for advanced hepatocellular carcinoma with regorafenib or cabozantinib: Multicenter French clinical experience in real-life after matching

R. Anty, L. Mineur, M. Bourlière, 2022, World journal of gastrointestinal oncology.

Acute Budd-Chiari syndrome with hepatic failure and obstruction of the inferior vena cava as presenting manifestations of hereditary protein C deficiency.

M. Bourlière, Y. L. Le Treut, M. Antoni, 1990, Gut.

Management of portal hypertension in patients treated with Atezolizumab and Bevacizumab for hepatocellular carcinoma.

P. Calame, C. Bureau, F. Oberti, 2022, Journal of hepatology.

Chronic hepatitis C: treatments of the future.

M. Bourlière, I. Portal, X. Adhoute, 2011, Clinics and research in hepatology and gastroenterology.

Natural presence of substitution R155K within hepatitis C virus NS3 protease from a treatment‐naïve chronically infected patient

P. Colson, C. Tamalet, R. Gérolami, 2008, Hepatology.

HEMOCYTE TYPES AND TOTAL AND DIFFERENTIAL COUNTS IN UNPARASITIZED AND PARASITIZED Anastrepha obliqua (DIPTERA, TEPHRITIDAE) LARVAE

P. Castellani, José Esequiel, 2002 .

Hepatocellular carcinoma recurrence in hepatitis C virus-related cirrhosis treated with direct-acting antivirals: a case–control study

J. Raoul, M. Bourlière, G. Pénaranda, 2018, European journal of gastroenterology & hepatology.

Future treatment of patients with HCV cirrhosis

M. Bourlière, I. Portal, X. Adhoute, 2012, Liver international : official journal of the International Association for the Study of the Liver.

Double guidewire endoscopic technique, a major evolution in endoscopic retrograde cholangiopancreatography: Results of a retrospective study with historical controls comparing two therapeutic sequential strategies

C. Boustière, R. Laugier, P. Grandval, 2017, Digestive endoscopy : official journal of the Japan Gastroenterological Endoscopy Society.

Transplantation hépatique de l’adulte: qui et quand greffer?

J. Hardwigsen, D. Botta‐Fridlund, P. Castellani, 1998 .

Budd-Chiari syndrome secondary to intracardiac extension of hepatocellular carcinoma. Two cases treated by radical resection.

Y. L. Le Treut, T. Caus, J. Hardwigsen, 2001, Hepato-gastroenterology.

Barcelona clinic liver cancer nomogram and others staging/scoring systems in a French hepatocellular carcinoma cohort

J. Blanc, J. Raoul, M. Bourlière, 2017, World journal of gastroenterology.

[Association of dermatomyositis and hepatocellular carcinoma. One case One case].

D. Botta‐Fridlund, P. Castellani, A. Gauthier, 1998, Gastroenterologie clinique et biologique.

Early operation for severe corrosive injury of the upper gastrointestinal tract.

B. Berthet, R. Assadourian, P. Castellani, 1996, The European journal of surgery = Acta chirurgica.

Combining non-invasive methods for assessment of liver fibrosis.

M. Bourlière, G. Pénaranda, M Bourlière, 2008, Gastroenterologie clinique et biologique.

Retreatment with TACE: the ABCR SCORE, an aid to the decision-making process.

J. Raoul, M. Bourlière, G. Pénaranda, 2015, Journal of hepatology.

Expected outcomes and patients’ selection before chemoembolization—“Six-and-Twelve or Pre-TACE-Predict” scores may help clinicians: Real-life French cohorts results

R. Anty, J. Raoul, M. Bourlière, 2021, World Journal of Clinical Cases.

[Guided puncture-cytology under electronic sectorial ultrasound endoscopy. Results in 26 patients].

J. Seitz, G. Monges, M. Giovannini, 1993, Gastroenterologie clinique et biologique.

[Fatal sub-fulminant hepatitis caused by cyproterone acetate. A new case].

C. Renou, I. Portal, P. Castellani, 1996, Gastroenterologie clinique et biologique.

[Hepatocellular carcinoma in a non-cirrhotic liver. Presentation of series of 77 operated patients].

Y. L. Le Treut, J. Hardwigsen, S. Garcia, 1999, Chirurgie; memoires de l'Academie de chirurgie.

Usefulness of staging systems and prognostic scores for hepatocellular carcinoma treatments.

J. Raoul, G. Pénaranda, J. Hardwigsen, 2016, World journal of hepatology.

NIACE score for hepatocellular carcinoma patients treated by surgery or transarterial chemoembolization

J. Raoul, G. Pénaranda, J. Bronowicki, 2017, European journal of gastroenterology & hepatology.

Optimized stepwise combination algorithms of non‐invasive liver fibrosis scores including Hepascore in hepatitis C virus patients

D. Ouzan, A. Tran, C. Renou, 2008, Alimentary pharmacology & therapeutics.

The Italian Cooperative Multiple Sclerosis case-control study: preliminary results on viral antibodies.

M. Barbi, P. Ferrante, P. Castellani, 1987, Italian journal of neurological sciences.

Is transjugular intrahepatic portosystemic shunt really deleterious for liver transplantation issue? A monocentric study on 86 liver transplanted patients.

J. Bartoli, G. Moulin, Y. L. Le Treut, 2001, Transplantation proceedings.

Management of gastric varices: a French national survey

M. Rudler, D. Thabut, C. Bureau, 2016, European journal of gastroenterology & hepatology.

Congenital intrathoracic herniation of the right liver--late presentation as anicteric cholestasis.

Y. L. Le Treut, J. Hardwigsen, P. Castellani, 2003, Hepato-gastroenterology.

Iatrogenic dissection of the portal vein during TIPS procedure

I. Lázár, P. Petit, G. Moulin, 2009, European Radiology.

Acute Budd-Chiari syndrome with hepatic failure and obstruction of the inferior vena cava as presenting manifestations of hereditary protein C deficiency.

M. Antoni, P. Castellani, D. Botta, 1990, Gut.

Outcomes and safety of atezolizumab plus bevacizumab in the treatment of hepatocellular carcinoma: treatment prognosis and comparison with tyrosine kinase inhibitors in a French multicenter matched real-life study.

R. Anty, L. Mineur, G. Pénaranda, 2024, European journal of gastroenterology & hepatology.

Intrahepatic Cholangiocarcinoma and Hepatocellular Carcinoma: Real-life Data on Liver Disease, Treatment and Prognosis

R. Anty, G. Pénaranda, X. Adhoute, 2023, Journal of clinical and translational hepatology.

Natural presence of substitution R155K within hepatitis C virus NS3 protease from a treatment‐naïve chronically infected patient

P. Colson, C. Tamalet, R. Gérolami, 2008, Hepatology.